First Trust Nasdaq Pharmaceuticals ETF Rating $27.23 +0.31 (+1.15%) As of 03:53 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends First Trust Nasdaq Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FTXH Aggregate RatingModerate Buy 2.60Holdings in FTXH have an aggregate rating of Moderate Buy based on 736 analyst ratings issued in the past year covering 49 companies (99.2% of the portfolio).FTXH Aggregate Price Target$27.23High Prediction$27.23Average Prediction$27.23Low Prediction$27.23Holdings in FTXH have an aggregate price target of $27.23 and a range of $27.23 to $27.23 covering 49 companies (99.2% of the portfolio).FTXH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust Nasdaq Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 FTXH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.83%BMYBristol-Myers Squibb$57.01+1.3%4.9169 of 5 stars2.29$56.27 -1.3%21Positive News7.17%PFEPfizer$26.63+1.2%4.9944 of 5 stars2.50$32.00 20.2%16Positive News7.06%ABBVAbbVie$172.41+0.5%4.9965 of 5 stars2.88$205.50 19.2%24Short Interest ↓Positive News6.80%JNJJohnson & Johnson$148.10+0.7%4.9894 of 5 stars2.43$173.27 17.0%14Upcoming EarningsAnalyst ForecastOptions VolumeNews CoveragePositive News6.53%MRKMerck & Co., Inc.$96.18-1.8%4.9993 of 5 stars2.67$123.00 27.9%21Analyst ForecastNews CoveragePositive News4.58%GILDGilead Sciences$92.96+1.2%4.5643 of 5 stars2.70$97.96 5.4%27Analyst RevisionPositive News4.12%CAHCardinal Health$127.81+1.2%4.8035 of 5 stars2.73$133.29 4.3%154.03%VTRSViatris$11.33+0.3%2.038 of 5 stars2.00$13.67 20.6%33.74%UTHRUnited Therapeutics$367.97+2.5%4.926 of 5 stars2.73$378.36 2.8%15Positive NewsHigh Trading Volume3.54%JAZZJazz Pharmaceuticals$121.43+0.2%4.9845 of 5 stars2.87$177.00 45.8%15Short Interest ↓News CoveragePositive News3.48%ZTSZoetis$167.50+1.0%4.8736 of 5 stars3.09$211.89 26.5%11News CoveragePositive News3.17%LLYEli Lilly and Company$741.98+2.2%4.9972 of 5 stars2.81$1,002.22 35.1%213.06%AMGNAmgen$274.81+1.0%4.8926 of 5 stars2.44$314.91 14.6%27News CoveragePositive News2.89%BIIBBiogen$140.98+0.3%4.6886 of 5 stars2.43$230.00 63.1%282.41%OGNOrganon & Co.$15.89+0.9%4.8778 of 5 stars2.40$21.33 34.3%5Positive News2.39%CRLCharles River Laboratories International$169.84+3.9%4.5909 of 5 stars1.94$209.00 23.1%16Short Interest ↑Analyst RevisionNews Coverage2.33%REGNRegeneron Pharmaceuticals$687.80+0.9%4.6201 of 5 stars2.65$1,015.38 47.6%23News Coverage1.85%MEDPMedpace$347.52+3.0%4.1287 of 5 stars2.45$380.56 9.5%11News Coverage1.61%NBIXNeurocrine Biosciences$145.88+1.8%4.913 of 5 stars2.83$164.81 13.0%231.60%ELANElanco Animal Health$12.04+0.1%4.4024 of 5 stars2.25$16.43 36.5%81.12%EXELExelixis$36.43+0.6%4.6945 of 5 stars2.53$35.50 -2.6%191.12%ALKSAlkermes$30.10+2.1%4.5425 of 5 stars2.64$36.00 19.6%111.10%HALOHalozyme Therapeutics$55.94+2.1%4.2973 of 5 stars2.60$60.89 8.8%10Short Interest ↑0.95%PBHPrestige Consumer Healthcare$79.36+1.0%3.2686 of 5 stars2.50$85.25 7.4%40.95%PRGOPerrigo$24.44+2.5%4.9592 of 5 stars2.40$35.00 43.2%50.79%CORTCorcept Therapeutics$61.11+10.5%4.115 of 5 stars3.00$65.25 6.8%50.73%TGTXTG Therapeutics$29.86+1.0%4.5703 of 5 stars2.83$40.67 36.2%60.69%PTGXProtagonist Therapeutics$38.10+3.5%2.9016 of 5 stars3.00$53.78 41.1%90.62%ITCIIntra-Cellular Therapies$126.50+0.2%3.8327 of 5 stars2.67$100.31 -20.7%150.62%ACLXArcellx$66.57+0.1%3.2663 of 5 stars3.13$105.93 59.1%15Short Interest ↑0.61%ALNYAlnylam Pharmaceuticals$264.99+7.6%4.4525 of 5 stars2.72$298.61 12.7%25Analyst Forecast0.60%TWSTTwist Bioscience$50.45+6.1%2.9208 of 5 stars2.70$51.90 2.9%10Gap Up0.59%VCELVericel$59.56+0.8%1.9053 of 5 stars3.00$62.14 4.3%70.57%INCYIncyte$73.47+2.1%4.7853 of 5 stars2.35$76.29 3.8%200.55%ACADACADIA Pharmaceuticals$17.89+1.8%4.0137 of 5 stars2.59$25.25 41.1%170.55%ADMAADMA Biologics$16.16+0.9%4.1763 of 5 stars3.25$21.25 31.5%4Short Interest ↑Gap Down0.51%ROIVRoivant Sciences$11.27+1.1%3.6601 of 5 stars2.88$17.93 59.1%80.50%BPMCBlueprint Medicines$111.96+1.7%1.1236 of 5 stars2.65$122.72 9.6%20Short Interest ↑0.50%EXASExact Sciences$54.26+4.9%4.819 of 5 stars2.94$72.94 34.4%18News Coverage0.49%INSMInsmed$76.75+5.8%2.3717 of 5 stars3.00$83.67 9.0%160.49%AMRXAmneal Pharmaceuticals$8.56+3.6%3.5241 of 5 stars2.80$10.00 16.8%5Short Interest ↓0.49%SRPTSarepta Therapeutics$116.79-1.0%4.9641 of 5 stars2.91$178.71 53.0%220.45%KRYSKrystal Biotech$151.55+2.1%4.8604 of 5 stars3.00$206.67 36.4%8Short Interest ↓0.44%KYMRKymera Therapeutics$43.70+7.6%2.7486 of 5 stars2.88$55.06 26.0%17Analyst Forecast0.44%VRTXVertex Pharmaceuticals$427.89+1.4%4.3126 of 5 stars2.52$490.38 14.6%31Positive News0.44%BMRNBioMarin Pharmaceutical$62.53+1.6%4.9979 of 5 stars2.74$94.20 50.6%230.40%IONSIonis Pharmaceuticals$32.68+4.0%4.2445 of 5 stars2.68$60.65 85.6%190.36%RNAAvidity Biosciences$30.84+6.6%1.1002 of 5 stars3.00$65.80 113.4%10Analyst Forecast0.34%VKTXViking Therapeutics$32.87+0.7%3.925 of 5 stars3.15$106.75 224.8%13News CoverageHigh Trading Volume This page (NASDAQ:FTXH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
